Bunge (BG) Q3 2025 Earnings Call Transcript

Bunge reported Q3 adjusted EPS of $2.27, roughly flat year over year, while adjusted segment EBIT jumped to $924 million from $559 million as Viterra integration and stronger soybean/softseed processing boosted results. Management reaffirmed 2025 adjusted EPS guidance of $7.30-$7.60 and said synergies are tracking at or ahead of plan, with most benefits expected in 2026-2027. Liquidity remains strong with $9.7 billion of unused committed credit facilities, and capital returns continued with $545 million of buybacks and $324 million of dividends year to date.

Analysis

The market is likely underestimating how quickly the combined footprint can convert “more scale” into a better trading machine, not just a bigger asset base. The first-order read is that earnings are stable and integration is on track; the second-order read is that Bunge now has materially better information density across origin, storage, transport, and processing, which should compress decision latency and improve capture of basis, freight, and legging opportunities. That matters most in a low-volatility, spot-driven tape because the winner is increasingly the operator with the best optionality, not the one relying on simple crush spread beta.

The near-term P&L remains hostage to policy timing, but the asymmetry is improving into 2026. A clearer U.S. biofuel regime would likely re-rate soybean oil and upstream crush economics before volumes fully show up, while elevated global stocks keep a lid on the old-style scarcity spike; that suggests a slower grind higher rather than a violent rerating. The biggest hidden catalyst is not just RVO, but the combination of higher Southern Hemisphere throughput and a more integrated merchandising franchise, which should lift utilization of storage/logistics assets and make grain earnings less seasonal and more monetizable.

The main contrarian risk is that investors anchor on reported EPS drag from acquisition debt and integration noise and miss that the value creation window is back-end loaded. If policy remains muddled into mid-2026, the stock could de-rate on “show me” fatigue before synergies and buybacks become visible in the run rate. But if management executes even halfway to plan, the leverage math improves quickly because CapEx should roll over materially after 2026, giving room for a larger capital-return story than the current market probably discounts.

Key Decisions for Investors

• Long BG vs. short a commodity-processing peer basket over 3-6 months: best risk/reward is on relative execution and integration optionality, not outright oilseed beta.
• Buy BG on pullbacks into policy headlines; use a staggered entry ahead of the Q4/early-2026 biofuel decision window, because the stock can rerate before margins fully inflect.
• Pair trade: long BG / short a pure grain-handler or crush-only name to express the thesis that integrated origin-to-processing networks monetize volatility better in a spot market.
• Consider BG Jan-2027 call spreads: limited downside, direct exposure to synergy realization and post-2026 CapEx inflection, with upside if the market starts capitalizing the lower WACC and higher ROIC.
• Reduce or hedge if the next policy update slips beyond year-end and soybean oil prices fail to respond; that would extend the “awaiting clarity” trade and cap near-term multiple expansion.